Literature DB >> 14661924

Structural determinants of P-glycoprotein-mediated transport of glucocorticoids.

Charles R Yates1, Cheng Chang, Jeffrey D Kearbey, Kazuto Yasuda, Erin G Schuetz, Duane D Miller, James T Dalton, Peter W Swaan.   

Abstract

PURPOSE: The aim of this study was to determine requisite structural features for P-glycoprotein-mediated transport of a series of structurally related glucocorticoids (GCs).
METHODS: Transport experiments were conducted in wild-type and stably transfected MDRI LLC-PK cell line. Transport efficiency (Teff = Peff, B-->A / Peff, A-->B) in both cell lines was compared as a measure of passive diffusion and P-glycoprotein-mediated transepithelial transport for each steroid. Three-dimensional structure-activity relationships were built to determine how specific structural features within the steroids affect their P-gp-mediated efflux.
RESULTS: Mean (+/- SD) Teff in LLC-PK cells was 1.1 +/- 0.17, indicating that differences in structure and partition coefficient did not affect drug flux in the absence of P-glycoprotein. Teff in L-MDRI cells ranged from 3.6 to 26.6, demonstrating the importance of glucocorticoid structure to P-glycoprotein transport. The rank order of Teff in MDR1 cells was: methylprednisolone> prednisolone > betamethasone > dexamethasone/prednisone > cortisol. There was no correlation between individual Teff values and partition coefficient. 3D-QSAR models were built using CoMFA and CoMSIA with a q2 (r2) of 0.48 (0.99) and 0.41 (0.95), respectively.
CONCLUSIONS: Nonpolar bulky substituents around the C-6alpha position, as well as a hydrogen-bond donor at position C-11, enhance P-glycoprotein affinity and cellular efflux, whereas bulky substituents at C-16 diminish transporter affinity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14661924     DOI: 10.1023/b:pham.0000003377.39548.f6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain.

Authors:  A M Karssen; O C Meijer; I C van der Sandt; P J Lucassen; E C de Lange; A G de Boer; E R de Kloet
Journal:  Endocrinology       Date:  2001-06       Impact factor: 4.736

2.  Chemosensitizing steroids: glucocorticoid receptor agonists capable of inhibiting P-glycoprotein function.

Authors:  D J Gruol; S Bourgeois
Journal:  Cancer Res       Date:  1997-02-15       Impact factor: 12.701

3.  Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site.

Authors:  R T Kroemer; E Koutsilieri; P Hecht; K R Liedl; P Riederer; J Kornhuber
Journal:  J Med Chem       Date:  1998-01-29       Impact factor: 7.446

4.  Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes.

Authors:  S I Hsu; L Lothstein; S B Horwitz
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

5.  Structural approach to partitioning: Estimation of steroid partition coefficients based upon molecular constitution.

Authors:  G L Flynn
Journal:  J Pharm Sci       Date:  1971-03       Impact factor: 3.534

6.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity.

Authors:  G Klebe; U Abraham; T Mietzner
Journal:  J Med Chem       Date:  1994-11-25       Impact factor: 7.446

7.  Profound differences in the transport of steroids by two mouse P-glycoproteins.

Authors:  D J Gruol; Q D Vo; M C Zee
Journal:  Biochem Pharmacol       Date:  1999-10-01       Impact factor: 5.858

8.  Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells.

Authors:  K M Barnes; B Dickstein; G B Cutler; T Fojo; S E Bates
Journal:  Biochemistry       Date:  1996-04-16       Impact factor: 3.162

9.  A new method for quantitating intracellular transport: application to the thyroid hormone 3,5,3'-triiodothyronine.

Authors:  B A Luxon; R A Weisiger
Journal:  Am J Physiol       Date:  1992-11

10.  Cortisol is transported by the multidrug resistance gene product P-glycoprotein.

Authors:  C K van Kalken; H J Broxterman; H M Pinedo; N Feller; H Dekker; J Lankelma; G Giaccone
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

View more
  30 in total

1.  Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.

Authors:  Laura B Jaeger; William A Banks; Jozsef L Varga; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-23       Impact factor: 11.205

Review 2.  Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.

Authors:  Mei Lan Chen; Mark S Sundrud
Journal:  Inflamm Bowel Dis       Date:  2016-05       Impact factor: 5.325

3.  Prednisone Pharmacokinetics During Pregnancy and Lactation.

Authors:  Rachel J Ryu; Thomas R Easterling; Steve N Caritis; Raman Venkataramanan; Jason G Umans; Mahmoud S Ahmed; Shannon Clark; Ira Kantrowitz-Gordon; Karen Hays; Brooke Bennett; Matthew T Honaker; Kenneth E Thummel; Danny D Shen; Mary F Hebert
Journal:  J Clin Pharmacol       Date:  2018-05-07       Impact factor: 3.126

4.  Reduced methylprednisolone clearance causing prolonged pharmacodynamics in a healthy subject was not associated with CYP3A5*3 allele or a change in diet composition.

Authors:  Su-Jun Lee; William J Jusko; Christine G Salaita; Karim A Calis; Michael W Jann; Vicky E Spratlin; Joyce A Goldstein; Yuen Yi Hon
Journal:  J Clin Pharmacol       Date:  2006-05       Impact factor: 3.126

Review 5.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

6.  Glutathione-S-transferase-P1 I105V polymorphism and response to antenatal betamethasone in the prevention of respiratory distress syndrome.

Authors:  Chiara Oretti; Sara Marino; Fabio Mosca; Maria Rosa Colnaghi; Sara De Iudicibus; Ilenia Drigo; Gabriele Stocco; Fiora Bartoli; Giuliana Decorti; Sergio Demarini
Journal:  Eur J Clin Pharmacol       Date:  2009-01-29       Impact factor: 2.953

Review 7.  Glucocorticoids and fetal programming part 2: Mechanisms.

Authors:  Vasilis G Moisiadis; Stephen G Matthews
Journal:  Nat Rev Endocrinol       Date:  2014-05-27       Impact factor: 43.330

8.  Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.

Authors:  Jun J Yang; Cheng Cheng; Wenjian Yang; Deqing Pei; Xueyuan Cao; Yiping Fan; Stanley B Pounds; Geoffrey Neale; Lisa R Treviño; Deborah French; Dario Campana; James R Downing; William E Evans; Ching-Hon Pui; Meenakshi Devidas; W P Bowman; Bruce M Camitta; Cheryl L Willman; Stella M Davies; Michael J Borowitz; William L Carroll; Stephen P Hunger; Mary V Relling
Journal:  JAMA       Date:  2009-01-28       Impact factor: 56.272

9.  Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids.

Authors:  Sudharshan Hariharan; Sriram Gunda; Gyan P Mishra; Dhananjay Pal; Ashim K Mitra
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

10.  Challenges predicting ligand-receptor interactions of promiscuous proteins: the nuclear receptor PXR.

Authors:  Sean Ekins; Sandhya Kortagere; Manisha Iyer; Erica J Reschly; Markus A Lill; Matthew R Redinbo; Matthew D Krasowski
Journal:  PLoS Comput Biol       Date:  2009-12-11       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.